A carregar...
ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?
Patients with coronavirus disease 2019 (COVID-19) have a wide variety of clinical outcomes ranging from asymptomatic to severe respiratory syndrome that can progress to life-threatening lung lesions. The identification of prognostic factors can help to improve the risk stratification of patients by...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7914632/ https://ncbi.nlm.nih.gov/pubmed/33567739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22041705 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|